Mitochondria-mediated ATP depletion by anti-cancer agents of the jasmonate family

Journal of Bioenergetics and Biomembranes

Volumn 39, Issue 1, 2007, Pages 51-57

  Goldin, Natalia ^a   Heyfets, Alina ^a   Reischer, Dorit ^a   Flescher, Eliezer ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Cancer; Energy; Glycolysis; Jasmonate; Plant

Indexed keywords

ADENOSINE TRIPHOSPHATE; JASMONIC ACID;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOENERGY; CANCER CELL; CANCER PREVENTION; CELL DEATH; CELL MEMBRANE PERMEABILITY; GLYCOLYSIS; HUMAN; LIVER CARCINOMA; MITOCHONDRIAL DNA DEPLETION; MITOCHONDRIAL MEMBRANE; NONHUMAN; PROTEIN FAMILY; SHORT SURVEY;

ADENOSINE TRIPHOSPHATE; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CYCLOPENTANES; ENERGY METABOLISM; HUMANS; MITOCHONDRIA; NEOPLASMS; OXIDATIVE PHOSPHORYLATION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 34249934157     PISSN: 0145479X     EISSN: 15736881     Source Type: Journal    
DOI: 10.1007/s10863-006-9061-y     Document Type: Short Survey

References (49)

1. Aito H, Aalto KT, Raivio KO (2002) Pediatr Res 52:40-45
2. Amin R, Kamitani H, Sultana H, Taniura S, Islam A, Sho A, Ishibashi M, Eling TE, Watanabe T (2003) Neurol Res 25:370-376
3. Ara G, Teicher BA (1996) Prostaglandins Leukot Essent Fatty Acids 54:3-16
4. Arathi G, Sachdanandam P (2003) J Pharm Pharmacol 55:1283-1290
5. Bellosillo B, Pique M, Barragan M, Castano E, Villamor N, Colomer D, Montserrat E, Pons G, Gil J (1998) Blood 92:1406-1414
6. Bentle MS, Reinicke KE, Bey EA, Spitz DR, Boothman DA (2006) J Biol Chem Published online ahead of print
7. Brenner C, Grimm S (2006) Oncogene 25:4744-4756
8. Chen LB (1988) Ann Rev Cell Biol 4:155-181
9. Chung YM, Bae YS, Lee SY (2003) Free Radic Biol Med 34:434-442
10. Cuezva JM, Krajewska M, de Heredia ML, Krajewski S, Santamaria G, Kim H, Zapata JM, Marusawa H, Chamorro M, Reed JC (2002) Cancer Res 62:6674-6681
11. Dang CV, Semenza GL (1999) Trends Biochem Sci 24:68-72
12. Debatin K-M, Poncet D, Kroemer G (2002) Oncogene 21:8786-8803
13. Elder DJ, Hague A, Hicks DJ, Paraskeva C (1996) Cancer Res 56:2273-2276
14. Fingrut O, Flescher E (2002) Leukemia 16:608-616
15. Fingrut O, Reischer D, Rotem R, Goldin N, Altboum I, Zan-Bar I, Flescher E (2005) Br J Pharmacol 146:800-808
16. Flescher E (2005) Anticancer Drugs 16:911-916
17. Flescher, E. (2007). Cancer Lett. 245:1-10
18. Frydman B, Bhattacharya S, Sarkar A, Drandarov K, Chesnov S, Guggisberg A, Popaj K, Sergeyev S, Yurdakul A, Hesse M, Basu HS, Marton LJ (2004) J Med Chem 47:1051-1059
19. Fulton AM (1987) J Natl Cancer Inst 78:735-741
20. Gaikwad A, Poblenz A, Haridas V, Zhang C, Duvic M, Gutterman J (2005) Clin Cancer Res 11:1953-1962
21. Galuzzi L, Larochette N, Zamzami N, Kroemer G (2006) Oncogene 25:4812-4830
22. Gerhäuser C, Lee SK, Kosmeder JW, Moriarty RM, Hamel E, Mehta RG, Moon EC, Pezzuto JM (1997) Cancer Res 57:3429-3435
23. Ghezzo F, Cesano L, Mognetti B, Pesce E, Pirro E, Corvetti G, Berta GN, Zingaro B, Di Carlo F (2005) Int J Oncol 26:697-702
24. Ha HC, Snyder SH (1999) PNAS (USA) 96:13978-13982
25. Hanif R, Pittas A, Feng Y, Koutsos MI, Qiao L, Staiano-Coico L, Shiff SI, Rigas B (1996) Biochem Pharmacol 52:237-245
26. Healy DA, Watson RW, Newscholme P (2002) Clin Sci (Lond.) 103:179-189
27. Isidoro A, Martinez M, Fernandez PL, Ortega AD, Santamaria G, Chamorro M, Reed JC, Cuezva JM (2004) Biochem J 378:17-20
28. Kim JH, Lee SY, Oh SY, Han SI, Park HG, Yoo MA, Kang HS (2004) Oncol Rep 12:1233-1238
29. Klampfer L, Cammenga J, Wisniewski HG, Nimer SD (1999) Blood 93:2386-2394
30. Komatsu N, Nakagawa M, Oda T, Muramatsu T (2000) J Biochem (Tokyo) 128:463-470
31. Kutty RK, Santostasi G, Horng J, Krishna G (1991) Toxicol Appl Pharmacol 107:377-388
32. Lee EJ, Park HG, Kang HS (2003) Int J Oncol 23:503-508
33. Levin M, Goldbarg S, Lindqvist A, Sward K, Roman C, Liu BM, Hulten LM, Boren J, Clyman RI (2005) Pediatr Res 57:801-805
34. Lyamzaev KG, Izyumov DS, Avetisyan VA, Yang F, Pletjushkina OY, Chernyak BV (2004) Acta Biochim Pol 51:553-562
35. Maschek G, Savaraj N, Priebe W, Braunschweiger P, Hamilton K, Tidmarsh GF, De Young LR, Lampidis TJ (2004) Cancer Res 64:31-34
36. Ordan O, Rotem R, Jaspers I, Flescher E (2003) Br J Pharmacol 138:1156-1162
37. Pedersen PL (1978) Prog Exp Tumor Res 22:190-274
38. Rotem R, Fingrut O, Moskovitz J, Flescher E (2003) Leukemia 17:2230-2234
39. Rotem R, Heyfets A, Fingrut O, Blickstein D, Shaklai M, Flescher E (2005) Cancer Res 65:1984-1993
40. Rotem R, Tzivony Y, Flescher E (2000) Prostate 42:172-180
41. Salomon AR, Voehringer DW, Herzenberg LA, Khosla C (2000) PNAS 97:14766-14771
42. Samaila D, Ezekwudo DE, Yimam KK, Elegbede JA (2004) Trans Integrated Biomed Inform Enabling Tech Symp J 1:34-42 (Published online at www.tibetsjournal.org)
43. Saraswathi V, Ramamoorthy N, Subramaniam S, Mathuram V, Gunasekaran P, Govindasamy S (1998) Chemotherapy 44:198-205
44. Shiff SJ, Koutsos MI, Qiao L, Rigas B (1996) Exp Cell Res 222:179-188
45. Sivalokanathan S, Hayaraja M, Balasubramanian MP (2005) Indian J Exp Biol 43:264-267
46. Sotiriou C, Lacroix M, Lagneaux L, Berchem G, Body JJ (1999) Anticancer Res 19:2997-3006
47. Tiwari BS, Belenghi B, Levine A (2002) Plant Physiol 128:1271-1281
48. Warburg O, Dickens F, Kaiser Wilhelm-Institut für Biologie B (1930) The Metabolism of Tumours: Investigations from the Kaiser-Wilhelm Institute for Biology, Berlin-Dahlem. Constable: London
49. Zong WX, Ditsworth D, Bauer DE, Wang ZQ, Thompson CB (2004) Genes Dev 18:1272-1282